{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:49:36Z","timestamp":1777589376791,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Endourology"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Bladder outflow obstruction (BOO) surgery is among the most commonly performed urologic procedures. Postoperative assessment consists of physical measurement of uroflowmetry and post-void residual volume, but health systems worldwide have experienced pressures in demand, leading to exploration of greater efficiency in organizing clinic protocols. International Prostate Symptom Score (IPSS) questionnaire measurement has been identified as a tool to predict change in postoperative management. Our institution established a nurse-led follow-up virtual clinic (VC) for patients undergoing BOO surgery based on IPSS measurement. We present the clinical and economic outcomes of this new service.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Patients with a successful postoperative trial without catheter were contacted by telephone via VC and discharged by a Urology Clinical Nurse Specialist (UCNS) if IPSS was &lt;8. Data were analyzed for IPSS, arrangement of subsequent clinic visits, and numbers discharged. Primary outcome was the proportion of patients discharged after VC consultation. Secondary outcomes were overall discharge rate following subsequent face-to-face (FTF) appointment; and the proportion of patients re-referred from Primary Care within 3 months of discharge from VC. Cost savings were calculated based on tariffs of \u00a3135 for first attendance with UCNS, \u00a3199 for uroflowmetry, and \u00a347.84 for VC appointment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The first 50 patients to be recipients of the new VC were included. The median IPSS and quality-of-life score were 13 (interquartile range [IQR] 5) and 3 (IQR 1), respectively. Thirty-nine (78%) patients were discharged from VC; 36 (72%) had IPSS &lt;8. Overall discharge rate following subsequent FTF appointment was 88%. Two patients discharged from VC (5.1%) were subsequently re-referred, neither of whom required additional treatment. Total cost savings with VC amounted to \u00a310,634.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Telephone follow-up for BOO surgery based on IPSS is clinically safe and cost-effective, providing greater efficiency for clinic protocols.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/end.2020.0319","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T02:48:41Z","timestamp":1594867721000},"page":"1161-1166","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Safety and Cost-Effectiveness of Follow-up Virtual Clinic for Bladder Outflow Obstruction Surgery"],"prefix":"10.1177","volume":"34","author":[{"given":"Piyush Bhargav","family":"Sarmah","sequence":"first","affiliation":[{"name":"Department of Urology, City Hospital, Birmingham, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham Alexander","family":"Broadley","sequence":"additional","affiliation":[{"name":"Department of Urology, New Cross Hospital, Wolverhampton, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sikandar","family":"Khwaja","sequence":"additional","affiliation":[{"name":"Department of Urology, Queen's Hospital Burton, Burton-on-Trent, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George Henry","family":"Delves","sequence":"additional","affiliation":[{"name":"Department of Urology, Queen's Hospital Burton, Burton-on-Trent, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,11,1]]},"reference":[{"key":"e_1_3_4_2_2","unstructured":"NHS Digital. Hospital Episode Statistics. Available at https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/hospital-episode-statistics Accessed March24 2020."},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.12.038"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urpr.2017.01.001"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-02882-9"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.22374\/jeleu.v2i2.36"},{"key":"e_1_3_4_7_2","unstructured":"NHS Improvement. National Tariff Payment System 2019\/20. Available at https:\/\/improvement.nhs.uk\/resources\/national-tariff\/#h2-tariff-documents Accessed May27 2020."},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2020.02.034"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1106"},{"key":"e_1_3_4_10_2","unstructured":"NHS England and NH S Improvement. Letter to chief executives of all NHS trusts and foundation trusts CC G accountable officers GPpractices and primary care networks and providers of community health services. March 17 2020. https:\/\/www.england.nhs.uk\/coronavirus Accessed March24 2020."},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15061"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m998"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14847"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000750"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2016.04.066"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"e0189174","DOI":"10.1371\/journal.pone.0189174","article-title":"Evaluating the impact of a \u201cvirtual clinic\u201d on patient experience, personal and provider costs of care in urinary incontinence: A randomised controlled trial","volume":"18","author":"Jones G","year":"2018","unstructured":"Jones G, , Brennan V, , Jacques R, et al. Evaluating the impact of a \u201cvirtual clinic\u201d on patient experience, personal and provider costs of care in urinary incontinence: A randomised controlled trial. PLoS One, 2018; 18:e0189174.","journal-title":"PLoS One"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1308\/rcsann.2018.0151"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-017-1615-y"},{"key":"e_1_3_4_19_2","unstructured":"Harrison S. Getting It Right First Time: Urology Programme National Specialty Report. NHS Improvement 2018."},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00434801"},{"key":"e_1_3_4_21_2","unstructured":"National Institute for Health and Clinical Excellence (2019). Lower urinary tract symptoms in men: Management (NICE guideline CG97). Available at: https:\/\/www.nice.org.uk\/guidance\/cg97"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030656"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-018-0118-x"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900472"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20041"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2004.06.022"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-8979"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1089\/end.2012.0505"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.34172\/jlms.2020.33"},{"key":"e_1_3_4_30_2","first-page":"7772","article-title":"Three year results of the prostatic urethral L.I.F.T. study","volume":"22","author":"Roehrborn CG","year":"2015","unstructured":"Roehrborn CG, , Rukstalis DB, , Barkin J, et al. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol, 2015; 22:7772\u20137782.","journal-title":"Can J Urol"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756287218793084"}],"container-title":["Journal of Endourology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/end.2020.0319","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/end.2020.0319","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/end.2020.0319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:17:09Z","timestamp":1777407429000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/end.2020.0319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1089\/end.2020.0319"],"URL":"https:\/\/doi.org\/10.1089\/end.2020.0319","relation":{},"ISSN":["0892-7790","1557-900X"],"issn-type":[{"value":"0892-7790","type":"print"},{"value":"1557-900X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]}}}